What is Verily?
Verily Life Sciences LLC is a U.S.-based healthcare technology company that operates as a subsidiary of Alphabet Inc. Established in 2015, Verily focuses on enhancing health outcomes by leveraging data-driven research and advanced digital health solutions. The company develops sophisticated software platforms, comprehensive analytics tools, and specialized clinical research systems. These offerings are meticulously designed to integrate and analyze vast quantities of biomedical and health-related data, positioning Verily at the forefront of health innovation and personalized medicine.
How much funding has Verily raised?
Verily has raised a total of $3.8B across 5 funding rounds:
Private Equity
$800M
Other Financing Round
$1B
Private Equity
$700M
Unspecified
$1B
Other Financing Round
$300M
Private Equity (2017): $800M with participation from Temasek
Other Financing Round (2019): $1B led by Temasek, Silver Lake, Alphabet, and Ontario Teachers' Pension Plan
Private Equity (2020): $700M supported by Alphabet, Inc., Silver Lake Management, L.L.C., Ontario Teachers' Pension Plan, and Temasek
Unspecified (2022): $1B featuring Alphabet
Other Financing Round (2026): $300M backed by UCHealth, University of Colorado Anschutz Medical Campus, and Alphabet
Key Investors in Verily
Alphabet
Alphabet Inc. is the parent company of Verily, a multinational technology conglomerate focused on a wide array of digital services and products, including search, cloud computing, and artificial intelligence. Its strategic investments often align with its long-term vision for technological advancement and market leadership.
Temasek
Temasek is a global investment company headquartered in Singapore, known for its generational investment approach. It actively invests in companies across various sectors, including technology and healthcare, seeking to foster sustainable growth and innovation.
Silver Lake
Silver Lake is a prominent global technology investment firm that specializes in large-scale private equity investments in the technology sector. The firm's backing indicates a strong belief in Verily's technological potential and market strategy.
What's next for Verily?
With its substantial enterprise-level backing and recent strategic investment, Verily is poised for significant expansion and innovation. The company's trajectory suggests a focus on scaling its data analytics capabilities and broadening the reach of its digital health solutions. Future developments are likely to involve deeper integration of AI and machine learning in its research platforms, potentially leading to breakthroughs in disease prevention, diagnostics, and personalized treatment strategies. Continued collaboration with healthcare providers and research institutions will be crucial for Verily to solidify its position as a leader in transforming healthcare through technology.
See full Verily company page
